Step 1: Understanding the Concept:
Purine catabolism culminates in the oxidation of hypoxanthine and xanthine to uric acid, catalyzed by the enzyme xanthine oxidase.
Step 2: Detailed Explanation:
1. Allopurinol is a structural isomer of hypoxanthine.
2. It acts as a potent competitive inhibitor of xanthine oxidase.
3. Upon binding, xanthine oxidase oxidizes allopurinol to Alloxanthine (oxypurinol), which remains tightly bound to the enzyme's active site, acting as a suicide/non-competitive inhibitor.
4. This blocks the conversion of purines to uric acid, reducing blood uric acid levels.
It is widely used clinically to treat hyperuricemia and gout. Cyclo-oxygenase and lipo-oxygenase are involved in arachidonic acid metabolism.
Step 3: Final Answer:
The correct option is 3, which corresponds to Allopurinol.